Point72 Asset Management, L.P. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 23 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$1,597,500
+6.0%
3,000,0000.0%0.01%
+25.0%
Q2 2023$1,506,865
+31.0%
3,000,0000.0%0.00%0.0%
Q1 2023$1,149,924
-70.5%
3,000,000
-57.1%
0.00%
-69.2%
Q4 2022$3,898,858
-0.0%
7,000,0000.0%0.01%
-18.8%
Q3 2022$3,899,000
+3.9%
7,000,0000.0%0.02%0.0%
Q2 2022$3,752,000
+3.1%
7,000,0000.0%0.02%
+14.3%
Q1 2022$3,638,000
-1.8%
7,000,0000.0%0.01%
-6.7%
Q4 2021$3,705,0007,000,0000.02%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2022
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 17,454,000$9,8263.09%
Affinity Asset Advisors, LLC 7,500,000$3,008,2500.99%
DCF Advisers, LLC 3,600,000$1,476,0000.90%
Context Capital Management, LLC 21,851$8,7640.74%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 32,000,000$13,1200.48%
SILVERBACK ASSET MANAGEMENT LLC 6,250,000$2,500,0000.34%
WHITEBOX ADVISORS LLC 20,600,000$8,159,6600.28%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,425,000$11,431,7480.23%
READYSTATE ASSET MANAGEMENT LP 5,500,000$2,206,0500.20%
DAVIDSON KEMPNER PARTNERS 25,000,000$9,432,5000.18%
View complete list of ESPERION THERAPEUTICS INC NE shareholders